Mesovarian leiomyomas in the rat.

Area of Science:

• Veterinary Pathology
• Pharmacology
• Toxicology

Background:

• Beta-stimulants are widely used medications.
• Ovarian tumors are a potential concern in long-term drug studies.
• The specific effects of Salbutamol and Terbutaline on rat ovaries require investigation.

Purpose of the Study:

• To investigate the potential of Salbutamol and Terbutaline to induce mesovarian leiomyomas in Sprague-Dawley rats.
• To determine if Propranolol can prevent Salbutamol-induced tumor development.
• To assess the persistence of induced tumors after treatment cessation.

Main Methods:

• Sprague-Dawley rats were administered Salbutamol and Terbutaline for prolonged periods.
• Concurrent administration of Propranolol with Salbutamol was evaluated.
• Tumor development and persistence were monitored over time, including a 44-week recovery period.

Main Results:

• Prolonged treatment with Salbutamol and Terbutaline induced mesovarian leiomyomas.
• Concurrent Propranolol administration prevented Salbutamol-induced tumor formation.
• Induced tumors did not regress or progress during the 44-week postdosing recovery period.
• The study documented the first known incidence of spontaneous mesovarian leiomyomas in rats.

Conclusions:

• Beta-stimulants Salbutamol and Terbutaline can induce ovarian tumors in rats.
• Beta-blocker Propranolol may counteract the tumor-inducing effects of Salbutamol.
• Induced mesovarian leiomyomas are persistent and do not regress post-treatment.